Niodita Gupta-Werner

Poster(s):

• (PA-008) Economic Value of Tocilizumab Prophylaxis to Prevent Cytokine Release Syndrome (CRS) During Outpatient Teclistamab (Tec) or Talquetamab (Tal) Initiation for Relapsed/refractory Multiple Myeloma (RRMM)
  Wednesday, September 17, 2025